Thursday, September 29, 2016

Bihasal Comp. 5 / 6.25




Bihasal Comp. 5/6.25 may be available in the countries listed below.


Ingredient matches for Bihasal Comp. 5/6.25



Bisoprolol

Bisoprolol fumarate (a derivative of Bisoprolol) is reported as an ingredient of Bihasal Comp. 5/6.25 in the following countries:


  • Vietnam

Hydrochlorothiazide

Hydrochlorothiazide is reported as an ingredient of Bihasal Comp. 5/6.25 in the following countries:


  • Vietnam

International Drug Name Search

Wednesday, September 28, 2016

Bayslowth




Bayslowth may be available in the countries listed below.


Ingredient matches for Bayslowth



Voglibose

Voglibose is reported as an ingredient of Bayslowth in the following countries:


  • Japan

International Drug Name Search

Benciderm




Benciderm may be available in the countries listed below.


Ingredient matches for Benciderm



Benzyl Benzoate

Benzyl Benzoate is reported as an ingredient of Benciderm in the following countries:


  • Peru

International Drug Name Search

Broncomucil




Broncomucil may be available in the countries listed below.


Ingredient matches for Broncomucil



Carbocisteine

Carbocisteine is reported as an ingredient of Broncomucil in the following countries:


  • Italy

International Drug Name Search

EpiPen




In the US, EpiPen (epinephrine systemic) is a member of the following drug classes: adrenergic bronchodilators, catecholamines, vasopressors and is used to treat Adams-Stokes Syndrome, Allergic Reactions, Asthma - acute, Asystole, AV Heart Block, COPD - Acute, Electromechanical Dissociation and Shock.

US matches:

  • EpiPen

  • EpiPen Auto-Injector

  • EpiPen Jr. Auto-Injector

  • EpiPen 2-Pak

  • EpiPen JR 2-Pak

  • EpiPen JR Auto-Injector

  • Epipen Jr

UK matches:

  • EpiPen Jr. Auto-Injector 0.15mg
  • EpiPen Auto-Injector 0.3mg
  • EpiPen Adrenaline (Epinephrine) Auto-Injector 0.3mg (SPC)
  • EpiPen Auto-Injector 0.3mg (SPC)
  • EpiPen Jr. Adrenaline (Epinephrine) Auto-Injector 0.15mg (SPC)
  • EpiPen Jr. Auto-Injector 0.15mg (SPC)

Ingredient matches for EpiPen



Epinephrine

Epinephrine is reported as an ingredient of EpiPen in the following countries:


  • Austria

  • Bahrain

  • Canada

  • Czech Republic

  • Denmark

  • Egypt

  • Finland

  • Hungary

  • Iceland

  • Iran

  • Iraq

  • Israel

  • Jordan

  • Kuwait

  • Lebanon

  • Netherlands

  • New Zealand

  • Poland

  • Qatar

  • Saudi Arabia

  • Singapore

  • South Africa

  • Sweden

  • Switzerland

  • United Arab Emirates

  • United Kingdom

  • United States

Epinephrine hydrochloride (a derivative of Epinephrine) is reported as an ingredient of EpiPen in the following countries:


  • Australia

  • Belgium

  • Norway

  • Portugal

  • United States

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

Gabapentina Ur




Gabapentina Ur may be available in the countries listed below.


Ingredient matches for Gabapentina Ur



Gabapentin

Gabapentin is reported as an ingredient of Gabapentina Ur in the following countries:


  • Spain

International Drug Name Search

Liza




Liza may be available in the countries listed below.


Ingredient matches for Liza



Lansoprazole

Lansoprazole is reported as an ingredient of Liza in the following countries:


  • India

International Drug Name Search

Tuesday, September 27, 2016

Dulcolax Pico Liquid





1. Name Of The Medicinal Product



Dulcolax® Pico Liquid, 5 mg / 5 ml, oral solution.


2. Qualitative And Quantitative Composition



Each 5ml of liquid contains 5 mg sodium picosulfate.



Dulcolax® Pico Liquid also contains methyl parahydroxybenzoate (E218), propyl parahydroxybenzoate (E216), ethanol and the colouring agent sunset yellow FCF (E110).



For full list of excipients , see section 6.1.



3. Pharmaceutical Form



Oral solution.



Golden orange coloured liquid, with a fruit-like odour and taste.



4. Clinical Particulars



4.1 Therapeutic Indications



Pharmacy only and GSL:



Short term relief of constipation



Pharmacy only:



For the management of constipation of any aetiology.



4.2 Posology And Method Of Administration



For oral administration



Unless otherwise prescribed by the doctor, the following dosages are recommended:



Pharmacy only and GSL:



Adults and children over 10 years:



One to two 5 ml spoonfuls (5 - 10 mg) at night.



Pharmacy only:



Children under 10 years:



Not to be taken by children under 10 years without medical advice.



Children (4 - 10 years):



Half to one 5 ml spoonful (2.5 - 5 mg) at night.



Children under 4 years:



The recommended dosage is 250 micrograms per kilogram body weight.



In the management of constipation, once regularity has restarted dosage should be reduced and can usually be stopped.



Diluent: Can be diluted with purified water.



4.3 Contraindications



DULCOLAX is contraindicated in patients with ileus, intestinal obstruction, acute abdominal conditions including appendicitis, acute inflammatory bowel diseases, and severe abdominal pain associated with nausea and vomiting which may be indicative of the aforementioned severe conditions.



DULCOLAX is also contraindicated in severe dehydration and in patients with known hypersensitivity to sodium picosulfate or any other component of the product.



4.4 Special Warnings And Precautions For Use



As with all laxatives, DULCOLAX should not be taken on a continuous daily basis for more than five days without investigating the cause of constipation.



Prolonged excessive use may lead to fluid and electrolyte imbalance and hypokalaemia.



DULCOLAX should not be taken by children under 10 years without medical advice.



Dulcolax® Pico Liquid contains 5.9 vol % ethanol (alcohol) i.e. up to 480 mg per dose, equivalent to 12 ml beer, 5 ml wine per dose. Harmful for those suffering from alcoholism.To be taken into account in pregnant or breast-feeding women, children and high-risk groups such as patients with liver disease, or epilepsy.



Dulcolax® Pico Liquid contains the preservatives methyl parahydroxybenzoate, propyl parahydroxybenzoate and the colouring agent sunset yellow FCF (E110) which may cause allergic reactions (possibly delayed).



4.5 Interaction With Other Medicinal Products And Other Forms Of Interaction



The concomitant use of diuretics or adreno-corticosteroids may increase the risk of electrolyte imbalance if excessive doses of DULCOLAX are taken.



Electrolyte imbalance may lead to increased sensitivity to cardiac glycosides.



Concurrent administration of antibiotics may reduce the laxative action of this product.



4.6 Pregnancy And Lactation



There are no adequate and well-controlled studies in pregnant women. Long experience has shown no evidence of undesirable or damaging effects during pregnancy.



Clinical data show that neither the active moiety of sodium picosulfate (BHPM or bis-(p-hydroxyphenyl)-pyridyl-2-methane) nor its glucuronides are excreted into the milk of healthy lactating females.



Nevertheless, as with all medicines, DULCOLAX should not be taken in pregnancy, especially the first trimester, and during breast feeding unless the expected benefit is thought to outweigh any possible risk and only on medical advice.



4.7 Effects On Ability To Drive And Use Machines



None stated.



4.8 Undesirable Effects



Adverse events have been ranked under headings of frequency using the following convention:



Very common (



Immune system disorders



Rare: Hypersensitivity including angioneurotic oedema and skin reactions.



Gastrointestinal disorders



Common: Abdominal discomfort, abdominal pain, abdominal cramps and diarrhoea.



Uncommon: Nausea, vomiting.



4.9 Overdose



Symptoms: If high doses are taken diarrhoea, abdominal cramps and a clinically significant loss of potassium and other electrolytes can occur.



Furthermore, cases of colonic mucosal ischaemia have been reported in association with doses of DULCOLAX considerably higher than those recommended for the routine management of constipation.



Laxatives when taken in chronic overdosage may cause chronic diarrhoea, abdominal pain, hypokalaemia, secondary hyperaldosteronism and renal calculi. Renal tubular damage, metabolic alkalosis and muscle weakness secondary to hypokalaemia have also been described in association with chronic laxative abuse.



Therapy: Within a short time of ingestion, absorption can be minimised or prevented by inducing vomiting or by gastric lavage. Replacement of fluids and correction of electrolyte imbalance may be required. This is especially important in the elderly and the young.



Administration of antispasmodics may be of some value.



5. Pharmacological Properties



5.1 Pharmacodynamic Properties



Sodium picosulfate is a locally acting laxative from the triarylmethane group, which after bacterial cleavage in the colon, has a dual-action with stimulation of the mucosa of both the large intestine and of the rectum. Stimulation of the mucosa of the large intestine results in colonic peristalsis, with promotion of accumulation of water, and consequently electrolytes, in the colonic lumen. This results in stimulation of defaecation, reduction of transit time and softening of the stool. Stimulation of the rectum causes increased motility and a feeling of rectal fullness. The rectal effect may help to restore the “call to stool” although its clinical relevance remains to be established.



5.2 Pharmacokinetic Properties



After oral ingestion, sodium picosulfate reaches the colon without any appreciable absorption. Therefore, enterohepatic circulation is avoided. The active laxative compound, bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM), is formed by bacterial cleavage in the intestine. Consequently, the onset of action of the preparation is usually between 6 - 12 hours, which is determined by the release of the active substance.



After oral administration, only small amounts of the drug are systemically available.



There is no relationship between the laxative effect and plasma levels of the active moiety.



5.3 Preclinical Safety Data



There are no pre-clinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.



6. Pharmaceutical Particulars



6.1 List Of Excipients



Sodium Carboxymethylcellulose



Methyl Parahydroxybenzoate (E218)



Propyl Parahydroxybenzoate (E216)



Glycerol



Aroma Tutti Frutti (flavouring)



Saccharin Sodium



FD & C Yellow 6 (E110) (colouring)



Ethanol 96%



0.1 M Sodium Hydroxide



Purified Water



6.2 Incompatibilities



None stated



6.3 Shelf Life



3 years



6.4 Special Precautions For Storage



Keep the container in the outer carton



6.5 Nature And Contents Of Container



Amber glass bottles with aluminium ROPP caps.



Pack sizes of 30, 40, 50, 60, 90, and 500 ml.



Amber glass bottles with polypropylene tamper-evident closure with expanded polyethylene (coated with LDPE) liner.



Pack sizes of 100, 250 and 300 ml.



Not all pack sizes may be marketed.



6.6 Special Precautions For Disposal And Other Handling



Not applicable.



7. Marketing Authorisation Holder



Boehringer Ingelheim Limited



Ellesfield Avenue



Bracknell



Berkshire



RG12 8YS



Trading as Boehringer Ingelheim Self-Medication Division



8. Marketing Authorisation Number(S)



PL 00015/0249



9. Date Of First Authorisation/Renewal Of The Authorisation



16th September 2005



10. Date Of Revision Of The Text



September 2010



11. LEGAL CATEGORY


90, 100, 250, 300, 500 ml : P



30, 40, 50, 60 ml : GSL




Clivarin




Clivarin may be available in the countries listed below.


Ingredient matches for Clivarin



Reviparin Sodium

Reviparin Sodium is reported as an ingredient of Clivarin in the following countries:


  • Bosnia & Herzegowina

  • Bulgaria

  • Croatia (Hrvatska)

  • Czech Republic

  • Germany

  • Greece

  • Hungary

  • Luxembourg

  • Poland

  • Portugal

  • Romania

  • Serbia

  • Slovakia

  • Slovenia

International Drug Name Search

Hydrocortisone Lotion




Ingredient matches for Hydrocortisone Lotion



Hydrocortisone

Hydrocortisone is reported as an ingredient of Hydrocortisone Lotion in the following countries:


  • United States

International Drug Name Search

Bronchotussine




Bronchotussine may be available in the countries listed below.


Ingredient matches for Bronchotussine



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Bronchotussine in the following countries:


  • Greece

  • Malta

International Drug Name Search

Bihyper




Bihyper may be available in the countries listed below.


Ingredient matches for Bihyper



Bendroflumethiazide

Bendroflumethiazide is reported as an ingredient of Bihyper in the following countries:


  • Taiwan

International Drug Name Search

FusePaq Tabradol


Generic Name: cyclobenzaprine (Oral route)

sye-kloe-BEN-za-preen

Commonly used brand name(s)

In the U.S.


  • Amrix

  • Fexmid

  • Flexeril

  • FusePaq Tabradol

Available Dosage Forms:


  • Capsule, Extended Release

  • Tablet

  • Suspension

Therapeutic Class: Skeletal Muscle Relaxant, Centrally Acting


Uses For FusePaq Tabradol


Cyclobenzaprine is used to help relax certain muscles in your body. It helps relieve the pain, stiffness, and discomfort caused by strains, sprains, or injuries to your muscles. However, this medicine does not take the place of rest, exercise or physical therapy, or other treatment that your doctor may recommend for your medical problem. Cyclobenzaprine acts on the central nervous system (CNS) to produce its muscle relaxant effects. Its actions on the CNS may also cause some of this medicine's side effects.


Cyclobenzaprine may also be used for other conditions as determined by your doctor.


Cyclobenzaprine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, cyclobenzaprine is used in certain patients with fibromyalgia syndrome (also called fibrositis or fibrositis syndrome).


Before Using FusePaq Tabradol


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Studies on this medicine have been done only in adult patients, and there is no specific information comparing use of cyclobenzaprine in children with use in other age groups.


Geriatric


Many medicines have not been studied specifically in older people. Therefore, it may not be known whether they work exactly the same way they do in younger adults or if they cause different side effects or problems in older people. There is no specific information comparing use of cyclobenzaprine tablets in the elderly with use in other age groups.


Because of the possibility of higher blood levels in the elderly as compared to younger adults, use of cyclobenzaprine extended-release capsules is not recommended in the elderly .


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Brofaromine

  • Clorgyline

  • Furazolidone

  • Iproniazid

  • Isocarboxazid

  • Lazabemide

  • Linezolid

  • Moclobemide

  • Nialamide

  • Pargyline

  • Phenelzine

  • Procarbazine

  • Rasagiline

  • Selegiline

  • Toloxatone

  • Tranylcypromine

Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Duloxetine

  • Tramadol

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Escitalopram

  • Fluoxetine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Glaucoma or

  • Problems with urination—Cyclobenzaprine can make your condition worse.

  • Heart or blood vessel disease or

  • Overactive thyroid—The chance of side effects may be increased.

  • Liver disease—Higher blood levels of cyclobenzaprine may occur, increasing the chance of side effects .

Proper Use of cyclobenzaprine

This section provides information on the proper use of a number of products that contain cyclobenzaprine. It may not be specific to FusePaq Tabradol. Please read with care.


Take this medicine only as directed by your doctor. Do not take more of it and do not take it more often than your doctor ordered. To do so may increase the chance of serious side effects.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For relaxing stiff muscles:
    • For the oral dosage form (tablets):
      • Adults and teenagers 15 years of age and older—The usual dose is 10 milligrams (mg) three times a day. The largest amount should be no more than 60 mg (six 10-mg tablets) a day.

      • Children and teenagers up to 15 years of age—Dose must be determined by your doctor.


    • For the oral dosage form (extended-release capsules):
      • Adults—The usual dose is 15 mg once a day. Some patients may require up to 30 mg (one 30 mg capsule or two 15 mg capsules) per day.

      • Children—Use and dose must be determined by your doctor .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using FusePaq Tabradol


It is very important that your doctor check your progress at regular visits. This will allow your doctor to see if the medicine is working properly and to decide if you should continue to take it.


This medicine will add to the effects of alcohol and other CNS depressants (medicines that slow down the nervous system, possibly causing drowsiness). Some examples of CNS depressants are antihistamines or medicine for hay fever, other allergies, or colds; sedatives, tranquilizers, or sleeping medicine; prescription pain medicine or narcotics; barbiturates; medicine for seizures; other muscle relaxants; or anesthetics, including some dental anesthetics. Check with your doctor before taking any of the above while you are using this medicine.


You should NOT use the extended-release capsules if you have used an MAO inhibitor (MAOI) such as Eldepryl®, Marplan®, Nardil®, or Parnate® within the past 14 days .


This medicine may cause some people to have blurred vision or to become drowsy, dizzy, or less alert than they are normally. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy or are not alert and able to see well.


Cyclobenzaprine may cause dryness of the mouth. For temporary relief, use sugarless candy or gum, melt bits of ice in your mouth, or use a saliva substitute. However, if your mouth continues to feel dry for more than 2 weeks, check with your medical doctor or dentist. Continuing dryness of the mouth may increase the chance of dental disease, including tooth decay, gum disease, and fungus infections.


If your condition does not improve within two or three weeks, or if it becomes worse, check with your doctor .


FusePaq Tabradol Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Stop taking this medicine and get emergency help immediately if any of the following effects occur:


Rare
  • Changes in the skin color of the face

  • fast or irregular breathing

  • large swellings that look like hives on the face, eyelids, mouth, lips, and/or tongue

  • puffiness or swelling of the eyelids or the area around the eyes

  • shortness of breath, troubled breathing, tightness in chest, and/or wheezing

  • skin rash, hives, or itching

Check with your doctor immediately if any of the following side effects occur:


Rare
  • Fainting

Symptoms of overdose
  • Convulsions (seizures)

  • drowsiness (severe)

  • dry, hot, flushed skin

  • fast or irregular heartbeat

  • hallucinations (seeing, hearing, or feeling things that are not there)

  • increase or decrease in body temperature

  • troubled breathing

  • unexplained muscle stiffness

  • unusual nervousness or restlessness (severe)

  • vomiting (occurring together with other symptoms of overdose)

Check with your doctor as soon as possible if any of the following side effects occur:


Rare
  • Clumsiness or unsteadiness

  • confusion

  • mental depression or other mood or mental changes

  • problems in urinating

  • ringing or buzzing in the ears

  • skin rash, hives, or itching occurring without other symptoms of an allergic reaction listed above

  • unusual thoughts or dreams

  • yellow eyes or skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Blurred vision

  • dizziness or lightheadedness

  • drowsiness

  • dryness of mouth

Less common or rare
  • Bloated feeling or gas, indigestion, nausea or vomiting, or stomach cramps or pain

  • constipation

  • diarrhea

  • excitement or nervousness

  • frequent urination

  • general feeling of discomfort or illness

  • headache

  • muscle twitching

  • numbness, tingling, pain, or weakness in hands or feet

  • pounding heartbeat

  • problems in speaking

  • trembling

  • trouble in sleeping

  • unpleasant taste or other taste changes

  • unusual muscle weakness

  • unusual tiredness

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: FusePaq Tabradol side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More FusePaq Tabradol resources


  • FusePaq Tabradol Side Effects (in more detail)
  • FusePaq Tabradol Use in Pregnancy & Breastfeeding
  • Drug Images
  • FusePaq Tabradol Drug Interactions
  • FusePaq Tabradol Support Group
  • 169 Reviews for FusePaq Tabradol - Add your own review/rating


Compare FusePaq Tabradol with other medications


  • Fibromyalgia
  • Migraine
  • Muscle Spasm
  • Sciatica
  • Temporomandibular Joint Disorder

Biperideno




Biperideno may be available in the countries listed below.


Ingredient matches for Biperideno



Biperiden

Biperiden is reported as an ingredient of Biperideno in the following countries:


  • Peru

International Drug Name Search

Bifuroksym




Bifuroksym may be available in the countries listed below.


Ingredient matches for Bifuroksym



Cefuroxime

Cefuroxime axetil (a derivative of Cefuroxime) is reported as an ingredient of Bifuroksym in the following countries:


  • Georgia

International Drug Name Search

Monday, September 26, 2016

Biloina




Biloina may be available in the countries listed below.


Ingredient matches for Biloina



Loratadine

Loratadine is reported as an ingredient of Biloina in the following countries:


  • Argentina

International Drug Name Search

Iflerit




Iflerit may be available in the countries listed below.


Ingredient matches for Iflerit



Fluprednidene

Fluprednidene 21-acetate (a derivative of Fluprednidene) is reported as an ingredient of Iflerit in the following countries:


  • Greece

Miconazole

Miconazole nitrate (a derivative of Miconazole) is reported as an ingredient of Iflerit in the following countries:


  • Greece

International Drug Name Search

Biguanex




Biguanex may be available in the countries listed below.


Ingredient matches for Biguanex



Chlorhexidine

Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Biguanex in the following countries:


  • Argentina

International Drug Name Search

Amoxycillin




Amoxycillin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Amoxycillin



Amoxicillin

Amoxicillin is reported as an ingredient of Amoxycillin in the following countries:


  • Poland

Amoxicillin trihydrate (a derivative of Amoxicillin) is reported as an ingredient of Amoxycillin in the following countries:


  • Australia

International Drug Name Search

Azulfidine Oral, Rectal


Generic Name: sulfasalazine (Oral route, Rectal route)

sul-fa-SAL-a-zeen

Commonly used brand name(s)

In the U.S.


  • Azulfidine

  • Azulfidine Entabs

  • Sulfazine

  • Sulfazine EC

In Canada


  • Alti-Sulfasalazine

  • Salazopyrin

Available Dosage Forms:


  • Suppository

  • Enema

  • Tablet

  • Tablet, Enteric Coated

Therapeutic Class: Gastrointestinal Agent


Chemical Class: Sulfonamide


Uses For Azulfidine


Sulfasalazine , a sulfa medicine, is used to prevent and treat inflammatory bowel disease, such as ulcerative colitis. It works inside the bowel by helping to reduce the inflammation and other symptoms of the disease. Sulfasalazine is sometimes given with other medicines to treat inflammatory bowel disease.


Sulfasalazine is also used to treat rheumatoid arthritis in patients who have not been helped by or who cannot tolerate other medicines for rheumatoid arthritis.


Sulfasalazine is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, sulfasalazine is used in certain patients with the following medical conditions:


  • Ankylosing spondylitis

Before Using Azulfidine


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Sulfasalazine should not be used in children up to 2 years of age because it may cause brain problems. However, sulfasalazine has not been shown to cause different side effects or problems in children over the age of 2 years than it does in adults.


Geriatric


This medicine has been tested and has not been shown to cause different side effects or problems in older people than it does in younger adults.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking this medicine, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Riluzole

Using this medicine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Cyclosporine

  • Digoxin

  • Warfarin

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Allergies, severe or

  • Asthma, bronchial—The risk of an allergic reaction to sulfasalazine may be increased

  • Blood problems or

  • Glucose-6-phosphate dehydrogenase deficiency (lack of G6PD enzyme)—Patients with these problems may have an increase in side effects affecting the blood

  • Intestinal blockage—Sulfasalazine will not reach the site of action in the bowel

  • Kidney disease or

  • Liver disease—Patients with kidney disease or liver disease may have an increased chance of side effects

  • Porphyria—Use of sulfasalazine may cause an attack of porphyria

  • Urinary blockage—Sulfasalazine may not be eliminated properly, causing an increased risk of side effects

Proper Use of sulfasalazine

This section provides information on the proper use of a number of products that contain sulfasalazine. It may not be specific to Azulfidine. Please read with care.


Do not give sulfasalazine to infants and children up to 2 years of age, unless otherwise directed by your doctor. It may cause brain problems.


Sulfasalazine is best taken right after meals or with food to lessen stomach upset. If stomach upset continues or is bothersome, check with your doctor.


Each dose of sulfasalazine should also be taken with a full glass (8 ounces) of water. Several additional glasses of water should be taken every day, unless otherwise directed by your doctor. Drinking extra water will help to prevent some unwanted effects of the sulfa medicine.


For patients taking the enteric-coated tablet form of this medicine:


  • Swallow tablets whole. Do not break or crush.

Keep taking this medicine for the full time of treatment , even if you begin to feel better after a few days. Do not miss any doses.


Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For prevention or treatment of inflammatory bowel disease:
    • For oral dosage forms (tablets, enteric-coated tablets):
      • Adults and teenagers—To start, 500 milligrams (mg) to 1000 mg (1 gram) every six to eight hours. Your doctor may then decrease the dose to 500 mg every six hours. Later, your doctor may change your dose as needed.

      • Children 2 years of age and over—Dose is based on body weight and must be determined by your doctor.
        • To start, the dose is usually:
          • 6.7 to 10 mg per kilogram (kg) (3.05 to 4.55 mg per pound) of body weight every four hours or

          • 10 to 15 mg per kg (4.55 to 6.82 mg per pound) of body weight every six hours or

          • 13.3 to 20 mg per kg (6.05 to 9.09 mg per pound) of body weight every eight hours.


        • Then, the dose is usually 7.5 mg per kg (3.41 mg per pound) of body weight every six hours.


      • Infants and children up to 2 years of age—Use is not recommended.


    • For rectal dosage form (enema):
      • Adults and teenagers—3 grams (1 unit), used rectally as directed, every night.

      • Children 2 years of age and over—Dose must be determined by your doctor.

      • Infants and children up to 2 years of age—Use is not recommended.



  • For treatment of rheumatoid arthritis:
    • For oral dosage forms (tablets, enteric-coated tablets):
      • Adults and teenagers—To start, 500 mg to 1000 mg (1 gram) daily. Your doctor may increase your dose as needed, but the dose is generally not more than 3000 mg (3 grams) a day.

      • For children ages 6 and over—30 to 50 mg per kg of body weight daily, divided into two doses. The medicine is usually started at a lower amount and gradually increased to the actual amount over a month. Typically the amount that is needed does not exceed 2 grams per day. The dose must be determined by your doctor.

      • Infants and children up to 2 years of age—Use is not recommended.



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Precautions While Using Azulfidine


It is very important that your doctor check your progress at regular visits. This medicine may cause blood problems, especially if it is taken for a long time.


If your symptoms (including diarrhea) do not improve within 1 or 2 months, or if they become worse, check with your doctor.


Sulfasalazine may cause blood problems. These problems may result in a greater chance of certain infections, slow healing, and bleeding of the gums. Therefore, you should be careful when using regular toothbrushes, dental floss, and toothpicks. Dental work should be delayed until your blood counts have returned to normal. Check with your medical doctor or dentist if you have any questions about proper oral hygiene (mouth care) during treatment.


Sulfasalazine may cause your skin to be more sensitive to sunlight than it is normally. Exposure to sunlight, even for brief periods of time, may cause a skin rash, itching, redness or other discoloration of the skin, or a severe sunburn. When you begin taking this medicine:


  • Stay out of direct sunlight, especially between the hours of 10:00 a.m. and 3:00 p.m., if possible.

  • Wear protective clothing, including a hat. Also, wear sunglasses.

  • Apply a sun block product that has a skin protection factor (SPF) of at least 15. Some patients may require a product with a higher SPF number, especially if they have a fair complexion. If you have any questions about this, check with your health care professional.

  • Apply a sun block lipstick that has an SPF of at least 15 to protect your lips.

  • Do not use a sunlamp or tanning bed or booth.

If you have a severe reaction from the sun, check with your doctor.


This medicine may also cause some people to become dizzy. Make sure you know how you react to this medicine before you drive, use machines, or do anything else that could be dangerous if you are dizzy. If this reaction is especially bothersome, check with your doctor.


Before you have any medical tests, tell the doctor in charge that you are taking this medicine. The results of the bentiromide (e.g., Chymex) test for pancreas function are affected by this medicine.


Azulfidine Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Aching of joints

  • fever

  • headache (continuing)

  • itching

  • skin rash

  • vomiting

Less common or rare
  • Aching of joints and muscles

  • back, leg, or stomach pains

  • bloody diarrhea

  • bluish fingernails, lips, or skin

  • chest pain

  • cough

  • difficult breathing

  • difficulty in swallowing

  • chills, or sore throat

  • general feeling of discomfort or illness

  • loss of appetite

  • pale skin

  • redness, blistering, peeling, or loosening of skin

  • unusual bleeding or bruising

  • unusual tiredness or weakness

  • yellow eyes or skin

Check with your doctor as soon as possible if any of the following side effects occur:


More common
  • Increased sensitivity of skin to sunlight

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Abdominal or stomach pain or upset

  • diarrhea

  • loss of appetite

  • nausea

In some patients this medicine may also cause the urine or skin to become orange-yellow. This side effect does not need medical attention.


Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: Azulfidine Oral, Rectal side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More Azulfidine Oral, Rectal resources


  • Azulfidine Oral, Rectal Side Effects (in more detail)
  • Azulfidine Oral, Rectal Use in Pregnancy & Breastfeeding
  • Drug Images
  • Azulfidine Oral, Rectal Drug Interactions
  • Azulfidine Oral, Rectal Support Group
  • 0 Reviews for Azulfidine Oral, Rectal - Add your own review/rating


Compare Azulfidine Oral, Rectal with other medications


  • Alopecia
  • Crohn's Disease
  • Crohn's Disease, Acute
  • Crohn's Disease, Maintenance
  • Inflammatory Bowel Disease
  • Juvenile Rheumatoid Arthritis
  • Lymphocytic Colitis
  • Rheumatoid Arthritis
  • Ulcerative Colitis
  • Ulcerative Colitis, Active
  • Ulcerative Colitis, Maintenance
  • Uveitis

Quinapril A




Quinapril A may be available in the countries listed below.


Ingredient matches for Quinapril A



Quinapril

Quinapril hydrochloride (a derivative of Quinapril) is reported as an ingredient of Quinapril A in the following countries:


  • Netherlands

International Drug Name Search

Friday, September 23, 2016

Bronchowern




Bronchowern may be available in the countries listed below.


Ingredient matches for Bronchowern



Ambroxol

Ambroxol hydrochloride (a derivative of Ambroxol) is reported as an ingredient of Bronchowern in the following countries:


  • Georgia

International Drug Name Search

Icopent




Icopent may be available in the countries listed below.


Ingredient matches for Icopent



Icosapent

Icosapent ethyl ester (a derivative of Icosapent) is reported as an ingredient of Icopent in the following countries:


  • Japan

International Drug Name Search

Nise




Nise may be available in the countries listed below.


Ingredient matches for Nise



Nimesulide

Nimesulide is reported as an ingredient of Nise in the following countries:


  • India

  • Myanmar

  • Russian Federation

  • Venezuela

International Drug Name Search

Bettamousse




Bettamousse may be available in the countries listed below.


Ingredient matches for Bettamousse



Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Bettamousse in the following countries:


  • Denmark

  • Finland

  • Ireland

  • Israel

  • Italy

  • Norway

  • Spain

  • Sweden

  • United Kingdom

International Drug Name Search

Bifopezon




Bifopezon may be available in the countries listed below.


Ingredient matches for Bifopezon



Cefoperazone

Cefoperazone is reported as an ingredient of Bifopezon in the following countries:


  • Vietnam

International Drug Name Search

Vapresan




Vapresan may be available in the countries listed below.


Ingredient matches for Vapresan



Enalapril

Enalapril maleate (a derivative of Enalapril) is reported as an ingredient of Vapresan in the following countries:


  • Argentina

International Drug Name Search

Bilosin




Bilosin may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Bilosin



Tylosin

Tylosin is reported as an ingredient of Bilosin in the following countries:


  • Ireland

  • United Kingdom

International Drug Name Search

Becloneb




Becloneb may be available in the countries listed below.


Ingredient matches for Becloneb



Beclometasone

Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Becloneb in the following countries:


  • Greece

International Drug Name Search

Oz Crema




Oz Crema may be available in the countries listed below.


Ingredient matches for Oz Crema



Miconazole

Miconazole is reported as an ingredient of Oz Crema in the following countries:


  • Peru

International Drug Name Search

Broncodil




Broncodil may be available in the countries listed below.


Ingredient matches for Broncodil



Salbutamol

Salbutamol sulfate (a derivative of Salbutamol) is reported as an ingredient of Broncodil in the following countries:


  • Sri Lanka

International Drug Name Search

Ifocris




Ifocris may be available in the countries listed below.


Ingredient matches for Ifocris



Ifosfamide

Ifosfamide is reported as an ingredient of Ifocris in the following countries:


  • Argentina

International Drug Name Search

Bronco Magimox




Bronco Magimox may be available in the countries listed below.


Ingredient matches for Bronco Magimox



Bromhexine

Bromhexine is reported as an ingredient of Bronco Magimox in the following countries:


  • Peru

International Drug Name Search

Allergy Relief


Generic Name: chlorpheniramine (KLOR fen IR a meen)

Brand Names: AHist, Aller-Chlor, Allergy Relief, C.P.M., Chlo-Amine, Chlor-Mal, Chlor-Trimeton, Chlor-Trimeton Allergy SR, Chlorphen, ChlorTan, Ed Chlor-Tan, Ed ChlorPed, PediaTan, TanaHist-PD, Triaminic Allergy, Wal-finate


What is Allergy Relief (chlorpheniramine)?

Chlorpheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Chlorpheniramine is used to treat sneezing, itching, watery eyes, and runny nose caused by allergies or the common cold.


Chlorpheniramine may also be used for purposes not listed in this medication guide.


What is the most important information I should know about Allergy Relief (chlorpheniramine)?


Do not give this medication to a child younger than 4 years old. Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Do not take chlorpheniramine if you are allergic to it.

Ask a doctor or pharmacist before taking chlorpheniramine if you have glaucoma, a stomach ulcer, severe constipation, kidney disease, urination problems, an enlarged prostate, or a thyroid disorder.


Ask a doctor or pharmacist before using any other cold, cough, or allergy medicine. Chlorpheniramine is contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine.


Chlorpheniramine may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Drinking alcohol can increase certain side effects of chlorpheniramine.

What should I discuss with my healthcare provider before taking Allergy Relief (chlorpheniramine)?


Do not take this medication if you are allergic to chlorpheniramine. Do not use chlorpheniramine if you have used an MAO inhibitor such as furazolidone (Furoxone), isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam, Zelapar), or tranylcypromine (Parnate) in the last 14 days. A dangerous drug interaction could occur, leading to serious side effects.

Ask a doctor or pharmacist if it is safe for you to take this medicine if you have:



  • glaucoma;




  • a stomach ulcer;




  • severe constipation;




  • kidney disease;




  • urination problems or an enlarged prostate; or




  • a thyroid disorder.




FDA pregnancy category B. Chlorpheniramine is not expected to harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Chlorpheniramine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby. Older adults may be more likely to have side effects from this medication.

How should I take Allergy Relief (chlorpheniramine)?


Use exactly as directed on the label, or as prescribed by your doctor. Do not use in larger or smaller amounts or for longer than recommended. Cold or allergy medicine is usually taken only for a short time until your symptoms clear up.


Take this medication with a full glass of water. Take chlorpheniramine with food or milk if it upsets your stomach. Do not crush, chew, break, or open an extended-release tablet or capsule. Swallow it whole. Breaking or opening the pill may cause too much of the drug to be released at one time.

Measure liquid medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.


This medication can cause unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.


Store at room temperature away from moisture and heat.

What happens if I miss a dose?


Since cold or allergy medicine is taken when needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. Skip the missed dose if it is almost time for your next scheduled dose. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.

Overdose symptoms may include feeling restless or nervous, nausea, vomiting, stomach pain, dizziness, drowsiness, dry mouth, warmth or tingly feeling, or seizure (convulsions).


What should I avoid while taking Allergy Relief (chlorpheniramine)?


Ask a doctor or pharmacist before using any other cold, cough, or allergy medicine. Chlorpheniramine is contained in many combination medicines. Taking certain products together can cause you to get too much of a certain drug. Check the label to see if a medicine contains an antihistamine.

Avoid becoming overheated or dehydrated during exercise and in hot weather. Chlorpheniramine can decrease perspiration and you may be more prone to heat stroke.


This medication may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be alert. Drinking alcohol can increase certain side effects of chlorpheniramine.

Allergy Relief (chlorpheniramine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat. Stop taking chlorpheniramine and call your doctor at once if you have a serious side effect such as:

  • urinating less than usual or not at all;




  • confusion, extreme drowsiness;




  • severe dizziness, anxiety, restless feeling, nervousness; or




  • weak or shallow breathing.



Less serious side effects may include:



  • mild dizziness, drowsiness;




  • blurred vision;




  • dry mouth;




  • nausea, stomach pain, constipation;




  • problems with memory or concentration; or




  • feeling restless or excited (especially in children).



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Allergy Relief (chlorpheniramine)?


Other cold or allergy medicine, sedatives, narcotic pain medicine, sleeping pills, muscle relaxers, and medicine for seizures, depression or anxiety can add to sleepiness caused by chlorpheniramine. Tell your doctor if you regularly use any of these medicines.

Tell your doctor about all other medicines you use, especially:



  • glycopyrrolate (Robinul);




  • mepenzolate (Cantil);




  • probenecid (Benemid, Probalan);




  • rifampin (Rifadin, Rifater, Rifamate, Rimactane);




  • zidovudine (Retrovir, AZT);




  • a diuretic (water pill);




  • atropine (Atreza, Sal-Tropine), belladonna (Donnatal, and others), benztropine (Cogentin), dimenhydrinate (Dramamine), methscopolamine (Pamine), or scopolamine (Transderm-Scop);




  • bladder or urinary medications such as darifenacin (Enablex), flavoxate (Urispas), oxybutynin (Ditropan, Oxytrol), tolterodine (Detrol), or solifenacin (Vesicare);




  • bronchodilators such as ipratropium (Atrovent) or tiotropium (Spiriva);




  • irritable bowel medications such as dicyclomine (Bentyl), hyoscyamine (Hyomax), or propantheline (Pro-Banthine); or




  • salicylates such as aspirin, Backache Relief Extra Strength, Novasal, Nuprin Backache Caplet, Doan's Pills Extra Strength, Pepto-Bismol, Tricosal, and others;



This list is not complete and other drugs may interact with chlorpheniramine. Tell your doctor about all medications you use. This includes prescription, over-the-counter, vitamin, and herbal products. Do not start a new medication without telling your doctor.



More Allergy Relief resources


  • Allergy Relief Side Effects (in more detail)
  • Allergy Relief Use in Pregnancy & Breastfeeding
  • Drug Images
  • Allergy Relief Drug Interactions
  • 0 Reviews for Allergy Relief - Add your own review/rating


  • Ahist MedFacts Consumer Leaflet (Wolters Kluwer)

  • Aller-Chlor Syrup MedFacts Consumer Leaflet (Wolters Kluwer)

  • Chlorpheniramine Maleate/Tannate, Dexchlorpheniramine Maleate Monograph (AHFS DI)

  • Ed ChlorPed Suspension Drops MedFacts Consumer Leaflet (Wolters Kluwer)

  • Pediox-S Suspension MedFacts Consumer Leaflet (Wolters Kluwer)

  • QDALL AR Sustained-Release Capsules MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Allergy Relief with other medications


  • Allergic Reactions
  • Cold Symptoms
  • Hay Fever
  • Urticaria


Where can I get more information?


  • Your pharmacist can provide more information about chlorpheniramine.

See also: Allergy Relief side effects (in more detail)


Progesterone Insert



Pronunciation: proe-JES-ter-one
Generic Name: Progesterone
Brand Name: Endometrin


Progesterone Insert is used for:

Supporting embryo implants and early pregnancy in certain women. It is also used as part of an assisted reproductive technology (ART) treatment program. It may also be used for other conditions as determined by your doctor.


Progesterone Insert is a hormone. It works by changing the lining of the uterus.


Do NOT use Progesterone Insert if:


  • you are allergic to any ingredient in Progesterone Insert

  • you have vaginal bleeding of an unknown cause, you have had a recent miscarriage, or the embryo is implanted outside the uterus (ectopic pregnancy)

  • you know or suspect that you have breast cancer

  • you have bleeding in the brain or severe blood vessel problems

  • you have a history of bleeding or blood clotting problems (eg, blood clots in the legs, lungs, or eyes), heart attack, stroke, or liver disease

  • you are using other vaginal products (eg, vaginal antifungal creams)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Progesterone Insert:


Some medical conditions may interact with Progesterone Insert. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of heart or blood vessel problems, depression or other mental/mood problems, or cancer

Some MEDICINES MAY INTERACT with Progesterone Insert. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Carbamazepine or rifampin because they may decrease Progesterone Insert's effectiveness

  • Other vaginal products (eg, vaginal antifungal creams) because they may alter Progesterone Insert's actions

This may not be a complete list of all interactions that may occur. Ask your health care provider if Progesterone Insert may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Progesterone Insert:


Use Progesterone Insert as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • An extra patient leaflet is available with Progesterone Insert. Talk to your pharmacist if you have questions about this information.

  • Wash your hands before and after using Progesterone Insert.

  • Unwrap the applicator and place one insert in the space provided at the end of the applicator.

  • You may use Progesterone Insert while standing, sitting, or when lying on your back with your knees bent. Gently place the thin end of the applicator well into the vagina. Push the plunger to release the insert, then remove the applicator and throw it away in the trash.

  • If you miss a dose of Progesterone Insert, use it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not use 2 doses at once.

Ask your health care provider any questions you may have about how to use Progesterone Insert.



Important safety information:


  • Progesterone Insert may cause drowsiness, dizziness, blurred vision, or lightheadedness. These effects may be worse if you take it with alcohol or certain medicines. Use Progesterone Insert with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not use Progesterone Insert at the same time as other vaginal therapy without checking with your doctor.

  • Progesterone Insert may cause harm if it is swallowed. If you may have taken it by mouth, contact your poison control center or emergency room right away.

  • Progesterone Insert should not be used in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Progesterone Insert is used to support early pregnancy. Progesterone Insert is found in breast milk. If you are or will be breast-feeding while you use Progesterone Insert, check with your doctor. Discuss any possible risks to your baby.


Possible side effects of Progesterone Insert:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Bloating; breast tenderness; constipation; cramping; drowsiness; fluid retention; headache; nausea; stomach pain; tiredness; vaginal burning or irritation; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (eg, rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); abnormal vaginal bleeding; calf or leg pain, swelling, or tenderness; change in emotions, mood, or behavior; chest pain; coughing up blood; fainting; one-sided weakness; pain in the groin; partial or complete loss of vision; stomach pain, swelling, or tenderness; sudden, severe headache, vomiting, dizziness, or fainting; sudden shortness of breath; swelling of hands, ankles, or feet; unusual vaginal itching, discharge, or odor; visual or speech disturbances; weakness or numbness in an arm or leg; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Progesterone side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.


Proper storage of Progesterone Insert:

Store Progesterone Insert at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat and light. Do not remove from the sealed foiled pouch until just before use. Keep Progesterone Insert out of the reach of children and away from pets.


General information:


  • If you have any questions about Progesterone Insert, please talk with your doctor, pharmacist, or other health care provider.

  • Progesterone Insert is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Progesterone Insert. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Progesterone resources


  • Progesterone Side Effects (in more detail)
  • Progesterone Use in Pregnancy & Breastfeeding
  • Progesterone Drug Interactions
  • Progesterone Support Group
  • 15 Reviews for Progesterone - Add your own review/rating


Compare Progesterone with other medications


  • Amenorrhea
  • Endometrial Hyperplasia, Prophylaxis
  • Perimenopausal Symptoms
  • Premature Labor
  • Progesterone Insufficiency
  • Seizures
  • Uterine Bleeding

Bifonazol Hexal




Bifonazol Hexal may be available in the countries listed below.


Ingredient matches for Bifonazol Hexal



Bifonazole

Bifonazole is reported as an ingredient of Bifonazol Hexal in the following countries:


  • Germany

International Drug Name Search

Hypen SR




Hypen SR may be available in the countries listed below.


Ingredient matches for Hypen SR



Indapamide

Indapamide is reported as an ingredient of Hypen SR in the following countries:


  • Bangladesh

International Drug Name Search

Nitrendipino Ratiopharm




Nitrendipino Ratiopharm may be available in the countries listed below.


Ingredient matches for Nitrendipino Ratiopharm



Nitrendipine

Nitrendipine is reported as an ingredient of Nitrendipino Ratiopharm in the following countries:


  • Spain

International Drug Name Search

Thursday, September 22, 2016

Bicalutamid Hexal




Bicalutamid Hexal may be available in the countries listed below.


Ingredient matches for Bicalutamid Hexal



Bicalutamide

Bicalutamide is reported as an ingredient of Bicalutamid Hexal in the following countries:


  • Austria

  • Germany

  • Luxembourg

International Drug Name Search

Losiral




Losiral may be available in the countries listed below.


Ingredient matches for Losiral



Letrozole

Letrozole is reported as an ingredient of Losiral in the following countries:


  • Chile

  • Ecuador

  • Peru

International Drug Name Search

Bronhall




Bronhall may be available in the countries listed below.


Ingredient matches for Bronhall



Bromhexine

Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Bronhall in the following countries:


  • Greece

International Drug Name Search

Benelaxa




Benelaxa may be available in the countries listed below.


Ingredient matches for Benelaxa



Gliclazide

Gliclazide is reported as an ingredient of Benelaxa in the following countries:


  • Japan

International Drug Name Search

Iron




Iron may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Iron



Iron Dextran

Iron Dextran is reported as an ingredient of Iron in the following countries:


  • Netherlands

International Drug Name Search

Oxaliprol




Oxaliprol may be available in the countries listed below.


Ingredient matches for Oxaliprol



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliprol in the following countries:


  • Greece

International Drug Name Search

Bifodron




Bifodron may be available in the countries listed below.


Ingredient matches for Bifodron



Risedronic Acid

Risedronic Acid monosodium (a derivative of Risedronic Acid) is reported as an ingredient of Bifodron in the following countries:


  • Slovakia

International Drug Name Search

Covangesic


Generic Name: acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine (a seet a MIN oh fen/klor fen IR a meen/pie RILL a meen/fen ill EFF rin/fen ill proe pa NOLE ameen)

Brand Names: Covangesic


What is Covangesic (acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine)?

Acetaminophen is a pain reliever and a fever reducer. It is used to treat many conditions, such as headache, muscle aches, arthritis, backache, toothaches, colds, and fevers.


Chlorpheniramine and pyrilamine are antihistamines. They work against the naturally occurring chemical histamine in the body. Chlorpheniramine and pyrilamine prevent sneezing; itchy, watery eyes and nose; and other symptoms of allergies and hay fever.


Phenylephrine and phenylpropanolamine are decongestants. They constrict blood vessels (veins and arteries). This reduces the blood flow to certain areas allowing nasal and respiratory (breathing) passages to open up.


Acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine is used to treat nasal congestion; itchy, watery eyes; itchy throat; sneezing; headache; fever; and other symptoms associated with allergies, hay fever, and the common cold.


Acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine may also be used for purposes other than those listed in this medication guide.


What is the most important information I should know about Covangesic (acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine)?


Use caution when driving, operating machinery, or performing other hazardous activities. Acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine may cause dizziness or drowsiness. If you experience dizziness or drowsiness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine. Alcohol may also cause damage to your liver when taken with acetaminophen.

Who should not take Covangesic (acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine)?


Do not take this medication without first talking to your doctor if you drink more than three alcoholic beverages per day or if you have had alcoholic liver disease. You may not be able to take acetaminophen if you have these conditions. Do not take this medication if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A serious drug interaction could occur, leading to side effects.

Before taking this medication, tell your doctor if you have


  • kidney disease,

  • liver disease,


  • diabetes,




  • glaucoma,




  • any type of heart disease or high blood pressure,




  • thyroid disease,




  • emphysema or chronic bronchitis, or




  • difficulty urinating or an enlarged prostate.



You may not be able to take acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine, or you may require a dosage adjustment or special monitoring during treatment if you have any of the conditions listed above.


It is not known whether acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine will harm an unborn baby. Do not take this medication without first talking to your doctor if you are pregnant. This medication passes into breast milk and may harm a nursing infant. Do not take this medication without first talking to your doctor if you are breast-feeding a baby. If you are over 60 years of age, you may be more likely to experience side effects from acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine. Read the package label for directions or consult your doctor or pharmacist before treating a child with this medication. Children are more susceptible than adults to the effects of medicines and may have unusual reactions.

How should I take Covangesic (acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine)?


Take acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine exactly as directed. If you do not understand these directions, ask your pharmacist, nurse, or doctor to explain them to you.


Take each dose with a full glass of water. Do not crush, chew, or break the long-acting or sustained-release tablets or capsules. Swallow them whole. If you are unsure about the formulation of your medicine, ask your pharmacist for help. If you have difficulty swallowing tablets or capsules, look for a liquid form of the medication.

To ensure that you get a correct dose, measure the liquid form of acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine with a special dose-measuring spoon or cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.


Never take more acetaminophen than is directed. The maximum amount of acetaminophen for adults is 1 gram (1000 mg) per dose and 4 grams (4000 mg) per day. Taking more acetaminophen could damage your liver. If you drink more than three alcoholic beverages per day, talk to your doctor before taking acetaminophen and never take more than 2 grams (2000 mg) per day.

Do not take acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine for longer than 7 to 10 days in a row. If your symptoms do not improve, if they get worse or if you have a fever, see your doctor.


Store acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine at room temperature away from moisture and heat.

What happens if I miss a dose?


Take the missed dose as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and take only the next regularly scheduled dose. Do not take a double dose of this medication.


What happens if I overdose?


Seek emergency medical attention.

Symptoms of an acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/ phenylpropanolamine overdose include a dry mouth, large pupils, flushing, nausea, vomiting, abdominal pain, diarrhea, seizures, confusion, sweating, and an irregular heartbeat.


What should I avoid while taking Covangesic (acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine)?


Use caution when driving, operating machinery, or performing other hazardous activities. Acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine may cause dizziness. If you experience dizziness, avoid these activities. Use alcohol cautiously. Alcohol may increase drowsiness and dizziness while you are taking acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine. Alcohol may also cause damage to your liver when taken with acetaminophen.

Acetaminophen and chlorpheniramine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine is taken with any of these medications.


Covangesic (acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine) side effects


If you experience any of the following serious side effects, stop taking acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine and seek emergency medical attention:

  • an allergic reaction (difficulty breathing; closing of your throat; swelling of your lips, tongue, or face; or hives);




  • liver damage (yellowing of the skin or eyes, nausea, abdominal pain or discomfort, unusual bleeding or bruising, or severe fatigue);




  • blood problems (easy or unusual bleeding or bruising); or




  • low blood sugar (fatigue, increased hunger or thirst, dizziness, or fainting).



Other, less serious side effects may be more likely to occur including:



  • dryness of the eyes, nose, and mouth;




  • drowsiness or dizziness;




  • blurred vision;




  • difficulty urinating; or




  • excitation in children.



Side effects other than those listed here may also occur. Talk to your doctor about any side effect that seems unusual or that is especially bothersome.


What other drugs will affect Covangesic (acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine)?


Do not take acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine if you have taken a monoamine oxidase inhibitor (MAOI) such as isocarboxazid (Marplan), phenelzine (Nardil), or tranylcypromine (Parnate) in the last 14 days. A serious drug interaction could occur, leading to side effects.

Urine glucose tests may produce false results while you are taking acetaminophen. Talk to your doctor if you are diabetic and you notice changes in your glucose levels during therapy with acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine.


Do not take other over-the-counter cough, cold, allergy, diet, pain, or sleep medicines while taking acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine without first talking to your doctor. Other medications may also contain chlorpheniramine, pyrilamine, phenylephrine, phenylpropanolamine, acetaminophen, or other similar drugs, and you may accidentally take too much of these medicines.


Acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine may increase the effects of other drugs that cause drowsiness, including antidepressants, alcohol, other antihistamines, pain relievers, anxiety medicines, seizure medicines, and muscle relaxants. Dangerous sedation, dizziness, or drowsiness may occur if acetaminophen/ chlorpheniramine/ pyrilamine/ phenylephrine/ phenylpropanolamine is taken with any of these medications.


Drugs other than those listed here may also interact with acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine. Talk to your doctor and pharmacist before taking any prescription or over-the-counter medicines.



More Covangesic resources


  • Covangesic Drug Interactions
  • Covangesic Support Group
  • 0 Reviews · Be the first to review/rate this drug


Where can I get more information?


  • Your pharmacist has additional information about acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine written for health professionals that you may read.

What does my medication look like?


Acetaminophen/chlorpheniramine/pyrilamine/phenylephrine/phenylpropanolamine is available over-the-counter under the brand name Convagesic. Other brand or generic formulations may also be available. Ask your pharmacist any questions you have about this medication, especially if it is new to you.